跳至主要内容
临床试验/NCT02034682
NCT02034682已完成不适用

The Effect of Hydroxyethylstarch 6% 130/0.4 in a Balanced Electrolyte Solution (Volulyte®) Compared to Gelatine (Geloplasma®) on Microvascular Reactivity and Tissue Oxygen Saturation During Haemodilution Measured With Near-infrared Spectroscopy

University Hospital, Ghent1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2014年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
1
主要终点
Value of the StO2 recovery slope (recStO2) after postocclusive ischaemia.

研究概览

简要总结

The aim of this study is to compare 6% hydroxyethyl starch (HES) 130/0.4 in a balanced electrolyte solution (Volulyte®) with modified fluid gelatin (Geloplasma®) as the priming solution for the cardiopulmonary bypass (CPB) circuit. The microvascular reactivity and the effects on tissue (StO2) and cerebral (ScO2) oxygen saturation will be examined using near-infrared spectroscopy (NIRS).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult consenting patients scheduled for elective coronary artery bypass grafting surgery on moderately hypothermic (> 32°C) CPB without blood transfusion. Age ≥ 18 years.

排除标准

  • Exclusion criteria are an ejection fraction < 25%, a known allergy to HES, admission of HES or gelatines within the preceding 2 weeks, renal insufficiency (creatinine > 2.0 mg/dl), significant hepatic disease (liver function tests > 3x upper limit of normal), history of cerebrovascular disease, significant carotid artery stenosis (> 60%), perioperative use of corticosteroids, and need for vasopressor or inotropic therapy before surgery. An expected haematocrit on CPB, calculated based on preoperative haematocrit, calculated blood volume and amount of cardioplegia, of < 23% is also considered an exclusion criterium

研究组 & 干预措施

Volulyte 6%

Experimental
  • Volulyte 6% (HES 130/0.4 in an isotonic composition). In 1000 ml:
  • Maize starch 60 gr. Molar substitution 0.38-0.45. 130000 Da
  • Na acetate trihydrate 4.63 gr
  • Sodium Chloride 6.02 gr
  • Potassium Chloride 0.3 gr
  • MgCl 0.3 gr
  • Sodium hydroxide-hydrochloric acid & H2O

干预措施: Volulyte 6% (Drug)

Geloplasma

Active Comparator

In 1000 ml:

  • Modified fluid gelatin 30 gr
  • Sodium Chloride 5.4 gr
  • Potassium Chloride 0.37 gr
  • MgCl 0.14 gr
  • Sodium lactate 3.36 gr

干预措施: Geloplasma (Drug)

结局指标

主要结局

Value of the StO2 recovery slope (recStO2) after postocclusive ischaemia.

时间窗: after 3 minutes of postocclusive ischaemia

Values are measured, using near-infrared spectroscopy.

次要结局

  • Change of values of ScO2 during cardiopulmonary bypass (CPB ).(Continuously during cardiopulmonary bypass (= maximum 3 hours).)
  • Change of value of StO2 during cardiopulmonary bypass.(Continuously during cardiopulmonary bypass(= maximum 3 hours).)
  • Change of blood gas analyses during cardiopulmonary bypass.(Continuously during cardiopulmonary bypass(= maximum 3 hours).)
  • Change of haemodynamics during cardiopulmonary bypass.(Continuously during cardiopulmonary bypass(= maximum 3 hours).)
  • Urinary output during cardiopulmonary bypass.(At the end of cardiopulmonary bypass(= after maximum 3 hours)..)
  • Use of vasoactive medication during cardiopulmonary bypass.(During complete cardiopulmonary bypass(= maximum 3 hours).)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

The Effect of Hydroxyethylstarch 6% 130/0.4 in a... | 临床试验